245 related articles for article (PubMed ID: 26101938)
21. Portopulmonary hypertension: an update.
Safdar Z; Bartolome S; Sussman N
Liver Transpl; 2012 Aug; 18(8):881-91. PubMed ID: 22674534
[TBL] [Abstract][Full Text] [Related]
22. Clinical aspects of portopulmonary hypertension.
Medarov BI; Chopra A; Judson MA
Respir Med; 2014 Jul; 108(7):943-54. PubMed ID: 24816204
[TBL] [Abstract][Full Text] [Related]
23. What's new in the treatment of portopulmonary hypertension?
DuBrock HM; Channick RN; Krowka MJ
Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):983-92. PubMed ID: 25882070
[TBL] [Abstract][Full Text] [Related]
24. Portopulmonary hypertension.
Hopps E; Valenti A; Caimi G
Clin Invest Med; 2011 Jun; 34(3):E111-8. PubMed ID: 21631986
[TBL] [Abstract][Full Text] [Related]
25. The impact of treatment of portopulmonary hypertension on survival following liver transplantation.
Ashfaq M; Chinnakotla S; Rogers L; Ausloos K; Saadeh S; Klintmalm GB; Ramsay M; Davis GL
Am J Transplant; 2007 May; 7(5):1258-64. PubMed ID: 17286619
[TBL] [Abstract][Full Text] [Related]
26. Treatment of portopulmonary hypertension--isn't it time to move forward?
Swanson KL
Liver Transpl; 2008 Mar; 14(3):270-1. PubMed ID: 18306388
[No Abstract] [Full Text] [Related]
27. Portopulmonary hypertension.
Krowka MJ
Semin Respir Crit Care Med; 2012 Feb; 33(1):17-25. PubMed ID: 22447257
[TBL] [Abstract][Full Text] [Related]
28. Multivisceral Transplant in a Patient With Portopulmonary Hypertension: A Case Report.
Livingstone J; Raveh Y; Souki F; Shatz V; Shah R; Ibrahim T; Shuman M; Beduschi T; Vianna R; Alvarez R; Nicolau-Raducu R
Transplant Proc; 2022; 54(6):1664-1670. PubMed ID: 35914967
[TBL] [Abstract][Full Text] [Related]
29. Portopulmonary hypertension: imatinib as a novel treatment and the Emory experience with this condition.
Tapper EB; Knowles D; Heffron T; Lawrence EC; Csete M
Transplant Proc; 2009 Jun; 41(5):1969-71. PubMed ID: 19545770
[TBL] [Abstract][Full Text] [Related]
30. Rapid normalization of portopulmonary hypertension after living donor liver transplantation.
Sugimachi K; Soejima Y; Morita K; Ueda S; Fukuhara T; Nagata S; Ikegami T; Taketomi A; Maehara Y
Transplant Proc; 2009 Jun; 41(5):1976-8. PubMed ID: 19545772
[TBL] [Abstract][Full Text] [Related]
31. Portopulmonary hypertension and right heart failure in patients with cirrhosis.
Ramsay M
Curr Opin Anaesthesiol; 2010 Apr; 23(2):145-50. PubMed ID: 20124995
[TBL] [Abstract][Full Text] [Related]
32. The perioperative management of portopulmonary hypertension with nitric oxide and epoprostenol.
Ramsay MA; Spikes C; East CA; Lynch K; Hein HA; Ramsay KJ; Klintmalm GB
Anesthesiology; 1999 Jan; 90(1):299-301. PubMed ID: 9915339
[No Abstract] [Full Text] [Related]
33. Current Approach to the Diagnosis and Management of Portopulmonary Hypertension.
Fussner LA; Krowka MJ
Curr Gastroenterol Rep; 2016 Jun; 18(6):29. PubMed ID: 27098816
[TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension.
Austin MJ; McDougall NI; Wendon JA; Sizer E; Knisely AS; Rela M; Wilson C; Callender ME; O'Grady JG; Heneghan MA
Liver Transpl; 2008 Mar; 14(3):287-91. PubMed ID: 18306330
[TBL] [Abstract][Full Text] [Related]
35. Progressive portopulmonary hypertension after liver transplantation treated with epoprostenol.
Rafanan AL; Maurer J; Mehta AC; Schilz R
Chest; 2000 Nov; 118(5):1497-500. PubMed ID: 11083710
[TBL] [Abstract][Full Text] [Related]
36. Sildenafil decreased pulmonary arterial pressure but may have exacerbated portal hypertension in a patient with cirrhosis and portopulmonary hypertension.
Wang YW; Lin HC; Yang YY; Hou MC; Lee SD
J Gastroenterol; 2006 Jun; 41(6):593-7. PubMed ID: 16868809
[TBL] [Abstract][Full Text] [Related]
37. Portopulmonary hypertension: Still an appropriate consideration for liver transplantation?
Verma S; Hand F; Armstrong MJ; de Vos M; Thorburn D; Pan T; Klinck J; Westbrook RH; Auzinger G; Bathgate A; Masson S; Holt A; Houlihan DD; Ferguson JW
Liver Transpl; 2016 Dec; 22(12):1637-1642. PubMed ID: 27593213
[TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol.
Fix OK; Bass NM; De Marco T; Merriman RB
Liver Transpl; 2007 Jun; 13(6):875-85. PubMed ID: 17539008
[TBL] [Abstract][Full Text] [Related]
39. Outcome of paediatric portopulmonary hypertension in the modern management era: A case report of 6 patients.
Joye R; Lador F; Aggoun Y; Farhat N; Wacker J; Wildhaber BE; Vallée JP; Hachulla AL; McLin VA; Beghetti M
J Hepatol; 2021 Mar; 74(3):742-747. PubMed ID: 33276028
[TBL] [Abstract][Full Text] [Related]
40. Portopulmonary hypertension as an indication for combined heart, lung, and liver or lung and liver transplantation: literature review and case presentation.
Scouras NE; Matsusaki T; Boucek CD; Wells C; Cooper EA; Planinsic RM; Sullivan EA; Bermudez CA; Toyoda Y; Sakai T
Liver Transpl; 2011 Feb; 17(2):137-43. PubMed ID: 21280186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
